SCHEMBL23484366

SCHEMBL23484366

Oc1ccc(OC(F)(F)F)c(O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.40
APP P05067 2/20 0.39
MAOB P27338 1/20 0.39
TYR P14679 3/20 0.37
PDE2A O00408 1/20 0.37
CES2 O00748 1/20 0.35
PDK2 Q15119 2/20 0.35
PDK4 Q16654 2/20 0.35
PDK1 Q15118 1/20 0.35
PDK3 Q15120 1/20 0.35
ALDH1A1 P00352 3/20 0.34
ALOX5 P09917 2/20 0.34
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA7 P43166 2/20 0.34
CA9 Q16790 2/20 0.34
CA14 Q9ULX7 2/20 0.34
NR1I2 O75469 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3026638 0.84 EPHX2 (0.41) EPHX2APPMAOBPDE2A
SCHEMBL8778326 0.83 MAOB (0.54) EPHX2APPMAOBTYRALDH1A1
SCHEMBL29623512 0.81 EPHX2 (0.54) EPHX2APPPDE2A
SCHEMBL25357651 0.81 CA3 (0.46) EPHX2APPPDE2ACA9CA14
SCHEMBL1253983 0.81 EPHX2 (0.54) EPHX2APPPDE2A
SCHEMBL10357217 0.81 KIF11 (0.40) EPHX2APPTYRPDE2AALDH1A1
SCHEMBL24436846 0.80 ALDH1A1 (0.46) TYRALDH1A1CA12CA1CA2
SCHEMBL24652321 0.79 SCN5A (0.41) EPHX2APPMAOBPDE2AALOX15
SCHEMBL263399 0.79 EPHX2 (0.38) EPHX2APPMAOBPDE2AALDH1A1
SCHEMBL365685 0.79 HSD17B10 (0.46) HSD17B10TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250042911-A1 NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF SPARK BIOPHARMA, INC. (KR) 2025-02-06 US disclosed
EP-4365175-A1 NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF Spark Biopharma, Inc. (KR) 2024-05-08 EP disclosed
CN-117897386-A Benzopyran derivatives and uses thereof 斯帕克生物制药有限公司 2024-04-16 CN disclosed
WO-2023277656-A1 NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF (주)스파크바이오파마 2023-01-05 WO disclosed
US-20210171883-A1 ANTIVIRAL WIPER FUJIFILM CORPORATION (JP) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171883-A1 ANTIVIRAL WIPER CGAS, PRKX, PDE4C EPHX2 956/4885APP 4813/4885MAOB 1521/4885
US-20250042911-A1 NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF MYD88, MYADM, CD14 EPHX2 2993/4885APP 4675/4885MAOB 3668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.